Pune, India, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Vaccines market size is expected to reach USD 125.49 billion in 2028, exhibiting a CAGR of 10.8% during the forecast period. Rising investments for effective medical products and rising demand for effective vaccination during the pandemic are expected to boost the market growth. As per the report, the market size stood at USD 55.44 billion in 2020 and USD 61.04 billion in 2021.
Vaccines are extremely useful to fight against several infections and reduce fatalities. It protects people from several infections globally. The rising demand for effective immunization is likely to boost the product’s sales. Rising investments in the development of effective medications are expected to boost the product’s demand. The increasing prevalence of infections and disorders is expected to boost the product’s demand. The geriatric population and children are prone to infections, which, in turn, leads to the adoption of effective vaccination. United Nations Children’s Funds (UNICEF) and Pan American Health Organization (PAHO) supply millions of vaccines to countries that require the vaccine. The rising adoption of medical solutions has led to a sudden decline in the prevalence of several diseases. This factor is expected to boost market growth during the upcoming years.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vaccines-market-101769
| Report Coverage | Details |
| Forecast Period | 2021-2028 |
| Forecast Period 2021 to 2028 CAGR | 10.8% |
| 2028 Value Projection | USD 125.49 billion |
| Base Year | 2020 |
| Market Size in 2020 | USD 55.44 billion |
| Historical Data for | 2017-2019 |
| No. of Pages | 156 |
| Segments covered | Type, Route of Administration, Disease Indication, Age Group, Distribution Channel, And Region |
| Growth Drivers | Robust Demand for the Product from the Healthcare Sectors to Boost Market Growth |
| Robust Supply and Rising R&D Activities to Drive Industry Growth |
Robust Supply and Rising R&D Activities to Drive Industry Growth
The rising prevalence of infections and disorders is expected to strengthen the supply of effective medical solutions. Hospitals, international organizations, government foundations, and pharmaceutical companies focus on providing effective immunization to the global population to reduce diseases and boost medical services’ effectiveness.
The Universal Immunization Programme (UPI) provided the pneumococcal conjugate vaccination to approximately 21 lakh children in Bihar and Himachal Pradesh in India. Rising demand for effective immunization solutions from underdeveloped and developing countries is likely to boost vaccine demand. Further, the emergence of several industry players such as Pfizer, Inovio Pharmaceuticals, Nordic, and Novavax are likely to fuel competition and enhance the production of effective vaccinations. These factors are likely to drive the vaccines market growth.
However, higher costs per vaccine are likely to hinder the market's progress during the upcoming years.
Robust Demand for the Product from the Healthcare Sectors to Boost Market Growth
This market is expected to be positively impacted during the COVID-19 pandemic because of the rising demand for high-quality vaccination from healthcare. The sudden spike in COVID-19 led to the adoption of effective medical solutions. Rising investments in effective medicines’ development are expected to boost its sales. The adoption of effective sanitization methods, production machinery, reduced capacities, and half-capacities may enable manufacturers to recover losses. Further, rising medical expenditures and the presence of several infections may boost industry growth during the pandemic.
Click here to get the short-term and long-term impacts of COVID-19 on this Market. Please visit: https://www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769
Increase in Pediatric Injection Doses Responsible for Majority Market Share
By type, the market is segmented into recombinant/conjugate/subunit, inactivated, live attenuated, and toxoid. As per the route of administration, it is bifurcated into oral and parenteral. Based on disease indication, it is categorized into bacterial diseases and viral diseases. By age group, it is segmented into adults and pediatric. By distributional channel, it is grouped into government suppliers, hospital & retail pharmacies, and others. Geographically, it is clubbed into Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa.
Quick Buy - Vaccines Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101769
Presence of Major Manufacturers and Effective Health Welfare Policies to Fuel Market Growth in North America
North America is expected to dominate the vaccines market share because of the presence of major manufacturers and effective health welfare policies. The market in North America stood at USD 29.43 billion in 2020 and is expected to grow positively during the upcoming years. Further, rising awareness regarding the benefits of vaccination is expected to boost the product demand. In addition, rising medical expenditures and the availability of developed medical infrastructure are expected to boost the product’s demand. These factors are likely to boost market growth.
In Asia-Pacific, the presence of heterogeneous economic development classes is expected to boost the product demand. Further, the rising population in India and China is expected to boost the product adoption. These factors are likely to propel industry market development.
The Report Lists the Key Companies in the Global Market
- Sumitomo Electric Industries (Osaka, Japan)
- PKC Group Ltd. (Helsinki, Finland)
- Yazaki Corporation (Tokyo, Japan)
- THB Group (London, U.K.)
- Lear Corporation (Michigan, U.S.)
- FURUKAWA ELECTRIC CO., LTD. (Tokyo, Japan)
- Nexans Autoelectric GmbH (Germany)
- Leoni AG (Nuremberg, Germany)
- Motherson (Noida, India)
- Spark Minda (New Delhi, India)
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/vaccines-market-101769
Global Vaccines Market Segmentation:
By Type:
- Recombinant/Conjugate/Subunit
- Inactivated
- Live Attenuated
- Toxoid
By Route of Administration:
- Parenteral
- Oral
By Disease Indication:
- Viral Diseases (Hepatitis, Influenza, Rotavirus)
- Bacterial Diseases
By Age Group:
- Pediatric
- Adults
By Distribution Channel:
- Hospital
- Retail Pharmacies
By Geography
- North America (USA, Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/vaccines-market-101769
Table Of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Industry Developments - Merger, Acquisitions, and Partnerships
4.2. Porter’s Five Forces Analysis
4.3. SWOT Analysis
4.4. Technological Developments
4.5. Value Chain Analysis
Continued…
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
